Development of a peripheral lung cancer model in rabbits using thoracoscopic-guided bronchoscopic inoculation Authors: Taek Yong Ko, Jin Hyuk Choi, Sun-Ju Oh, Dahae Yang, Ju Young Na, Sooyong Lee, Jesang Yu Published: 2026 ABSTRACT BackgroundIn preclinical research, tumor models are most commonly established by direct inoculation of tumor cell suspensions into the target organ. In the lung, however, precise delivery to a designated site is technically difficult, and leakage of cells into adjacent tissues such as the pleural cavity may cause diffuse spread rather than localized tumor formation. A model that reproducibly forms a tumor at a predetermined peripheral location would provide a useful experimental platform for studies on surgical approaches or stereotactic body radiation therapy (SBRT). This study aimed to develop such a peripheral lung cancer model in rabbits.MethodsNew Zealand White rabbits were anesthetized with intramuscular ketamine and xylazine, intubated, and maintained on sevoflurane. A flexible bronchoscope (3.7-mm outer diameter) was advanced to the orifice of the lateral segment of the right lower lobe, and a 1-mm Teflon catheter was passed through its working channel into the segmental bronchus under direct vision. Through a small intercostal incision, a thoracoscope was introduced, and the parenchymal site corresponding to the catheter tip was identified. Under thoracoscopic guidance, a VX2 tumor cell suspension, alone or mixed with lipiodol, was injected through the catheter. Tumor progression was monitored by serial chest radiography at 2 and 4 weeks. At week 5, the animals were euthanized, and the trachea and right lung were resected en bloc for histopathological analysis.ResultsTumor formation was observed in six rabbits. Among animals given the optimized protocol (larger rabbits injected with the VX2-lipiodol mixture), four of five developed pulmonary tumors and three showed tumors localized to the intended peripheral region, whereas tumors induced with VX2 alone grew invasively without peripheral localization. Histopathological examination confirmed malignancy at the target site.ConclusionsThoracoscopy-guided bronchoscopic inoculation, particularly when combined with lipiodol, enabled localized establishment of peripheral lung tumors in rabbits. The model provides a basis for developing preclinical platforms to evaluate diagnostic modalities and localized therapies such as SBRT, although further refinement and validation are required. Highlight box Key findings • A novel image-guided bronchoscopic technique enabled precise and reproducible establishment of peripheral lung tumors in rabbits. What is known and what is new? • Conventional orthotopic lung tumor models are commonly established by direct injection of tumor cell suspensions into the lung parenchyma. However, accurate localization of tumors within the peripheral lung is technically difficult, and tumor cell leakage frequently results in diffuse intrathoracic spread. These limitations reduce the reproducibility and translational value of preclinical models for stereotactic body radiation therapy (SBRT) research. • This study introduces a thoracoscopy-guided bronchoscopic inoculation technique that enables real-time visualization and anatomically precise delivery of VX2 tumor cells into the peripheral lung. Mixing VX2 cells with lipiodol improved localization and reduced tumor leakage, supporting the feasibility of forming localized peripheral lung tumors suitable for translational SBRT and image-guided intervention studies. What is the implication, and what should change now? • This technique may help improve the reproducibility and anatomical precision of preclinical lung cancer models, pending further validation with larger cohorts and refined technique, before more reliable evaluation of SBRT dose escalation can be pursued. Future preclinical studies investigating localized lung cancer treatment should consider using image-guided bronchoscopic tumor implantation with lipiodol to minimize tumor leakage and improve experimental consistency. Introduction Despite advances in therapeutic strategies and technologies, lung cancer remains the leading cause of cancer-related mortality worldwide (1). The primary treatment modalities include surgery, radiotherapy, and chemotherapy, selected according to tumor size, anatomical location, and patient condition (2). Because reliable preclinical models are required to develop and refine these local treatments, the ability to generate tumors at defined anatomical sites in animals is of central importance. Stereotactic body radiation therapy (SBRT) has emerged as an important alternative to surgery for early-stage lung cancer (3-5). SBRT delivers highly conformal radiation with steep dose gradients, allowing effective tumor control while sparing surrounding normal tissues. In addition to its role in early-stage disease, SBRT has also been applied to peripheral primary lesions in advanced lung cancer to reduce the tumor burden, achieving favorable clinical outcomes (6). Furthermore, when combined with systemic therapies such as immunotherapy or targeted therapy, SBRT may enhance treatment efficacy and improve oncological outcomes (7). A variety of preclinical lung tumor models have been developed, including spontaneous or chemically induced tumors, genetically engineered mouse models, and cell line–derived or patient-derived xenografts. Although these systems have advanced our understanding of tumor biology, most produce tumors at random or diffuse locations and are therefore poorly suited to studies that require a tumor at a defined anatomical site. The VX2 carcinoma, a rapidly growing squamous cell tumor of rabbit origin, has been widely used in interventional oncology because it forms solid, hypervascular tumors that are readily visualized and reproducibly propagated in immunocompetent rabbits; it has been applied to liver, kidney, and lung models, including recent image-guided studies of lung tumors (8). The rabbit also provides a body size sufficient for simultaneous thoracoscopy and bronchoscopy. We therefore selected the VX2 model in rabbits to develop a peripheral lung tumor with controlled localization, while recognizing that its molecular resemblance to human lung cancer is limited. Despite these advances, several clinical challenges remain. The optimal integration of SBRT with systemic therapies, and potential toxicities associated with combined treatments have not been fully established. Moreover, improving local tumor control remains an important goal for patients with primary and metastatic lung tumors treated with SBRT. Radioresistant tumor histology and larger tumor volumes may require higher radiation doses to achieve adequate tumor control. Although current treatment regimens demonstrate promising efficacy in selected patients, suboptimal local control persists in certain tumor subtypes, providing a clinical rationale for exploring radiation dose escalation strategies. Optimized SBRT regimens require reliable preclinical models that allow the systematic evaluation of radiation dose escalation and tolerance of healthy tissue. However, existing experimental systems are unable to consistently generate tumors at predetermined anatomical locations in animal models. This limitation significantly restricts the usefulness of conventional tumor models for SBRT research in which accurate tumor localization is essential for establishing high-precision radiation delivery. This challenge is particularly relevant to lung SBRT studies. Respiratory motion causes substantial internal tumor displacement during the breathing cycle, ranging from several millimeters to more than a centimeter in some cases (9). Such respiratory motion introduce geometric uncertainties that complicate target localization and treatment delivery in clinical practice. Without reproducible tumor placement at known anatomical sites, preclinical models cannot adequately simulate these motion-related uncertainties or replicate the technical challenges encountered in clinical SBRT (10,11). Several experimental approaches have been used to generate lung tumors in animal models, most commonly through direct injection of tumor cells into the lung parenchyma. However, these techniques have important limitations. Because the lungs are located deep within the thoracic cavity and cannot be visualized directly, the accurate delivery and verification of tumor cell deposition are technically challenging. Clinical studies of computed tomography (CT)-guided percutaneous lung biopsy, with procedures that involve similar techniques, report complications such as pulmonary hemorrhage in up to 36% of cases and pneumothorax in approximately 40% (12). In addition, leakage of injected tumor cell suspensions can lead to poorly demarcated tumors or unintended tumor formation in adjacent tissues. However, current approaches do not permit real-time visualization of tumor cell deposition during implantation. Importantly, the lack of a reliable method for generating anatomically precise lung tumors has limited the development of preclinical SBRT models that faithfully replicate the spatial- and motion-related challenges encountered in clinical lung radiotherapy. A model enabling controlled tumor placement with direct visualization during implantation may improve experimental reproducibility and facilitate a more rigorous evaluation of radiation dose escalation strategies. Such a platform could bridge the critical gap between experimental radiation biology and clinical SBRT practice. To address these limitations, we developed a novel method that enables real-time visualization during tumor-cell injection. We hypothesized that direct visualization of the injection process would allow for more precise localization of tumor cells and would improve the reproducibility of peripheral lung tumor models. Specifically, a thoracoscopic technique using a bronchoscope was designed to deliver tumor cells through the bronchial tree to distal airway branches, enabling targeted implantation within the peripheral lung parenchyma (Figure 1). Schematic diagram of the experiment. A Teflon catheter was advanced to the target bronchus via bronchoscopy, and cancer cells were inoculated under thoracoscopic guidance. This approach allows simultaneous thoracoscopic guidance and visual confirmation of the injection sites, enabling the immediate assessment of potential tumor cell leakage into the thoracic cavity. In addition, because the bronchoscopic route is used for tumor implantation, subsequent tumor evaluation using endobronchial ultrasonography can be readily performed. The model also enables the evaluation of procedural reproducibility between normal and tumor-bearing rabbits while allowing longitudinal assessment of vascular and mucosal changes. This study aimed to develop and validate a reproducible bronchoscopic technique for generating anatomically precise peripheral lung tumors in rabbits. Establishing such a model may improve the quality of preclinical SBRT research and provide an experimental platform for evaluating radiation dose escalation strategies and their therapeutic efficacy in lung cancer. We present this article in accordance with the ARRIVE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1080/rc). Methods Animal selection All animal experiments were performed under a project license (No. KMAP-20-5) granted by the Institutional Animal Care and Use Committee of Kosin University College of Medicine, in compliance with the institutional guidelines of Kosin University College of Medicine for the care and use of animals. Experiments were performed using 20 New Zealand White rabbits (2.0–4.0 kg; Hyochang Science, Daegu, Republic of Korea). All animals were housed individually under controlled environmental conditions and were provided free access to food and water throughout the experimental period to allow acclimatization. Although large animals, such as dogs, are often used in thoracic surgical experiments, they are costly and challenging to maintain. Conversely, small animals such as mice are unsuitable for this study because both thoracoscopy and bronchoscopy are required. Therefore, the New Zealand White rabbit was selected as the optimal model species because it offers sufficient body size for endoscopic manipulation while remaining cost-effective and easy to handle. Animals were divided into two groups: one group received an injection of VX2 tumor cell suspension, and the other received a mixture of VX2 tumor cells and lipiodol ultra fluid (Guerbet, Villepinte, France). The VX2 carcinoma cell line was selected because it has been previously validated for establishing orthotopic lung tumor models in rabbits, including CT-guided solitary lung tumor models (1), despite its more frequent application in hepatic and musculoskeletal tumor research. All procedures, including anesthesia, monitoring, and euthanasia, were conducted in accordance with institutional animal welfare guidelines of Kosin University College of Medicine. Selection of the tumor injection site The lateral segment of the right lower lobe was designated as the tumor cell injection site. This segment is the most lateral bronchus after the superior segmental bronchus and allows direct visualization of parenchymal expansion under thoracoscopic monitoring. The lateral segment offers easier bronchoscopic access and clearer visualization of parenchymal inflation than the superior segment during tumor cell delivery under direct endoscopic observation. In vivo propagation of VX2 tumor cells VX2 carcinoma cells were inoculated in the hind limbs of New Zealand White rabbits. After the induction of inhalational anesthesia with sevoflurane, the hind limb was shaved and disinfected with povidone-iodine solution. The VX2 tumor tissue was excised, and the necrotic portions were carefully removed. Viable tumor fragments were rinsed in 3 mL of phosphate-buffered saline and implanted into the prepared hind limb site to establish a tumor-bearing donor rabbit (Figure 2). Cancer cell propagation in rabbit models. Cancer cells were injected into the rabbit’s thigh, resulting in localized cancer formation. Experimental protocol The rabbits were anesthetized via intramuscular injection of ketamine (5 mg/kg) combined with xylazine (0.8 mg/kg). Following endotracheal intubation using a 5-mm tube, the animals were connected to a mechanical ventilator. Ventilation parameters were maintained, with tidal volume of 8 mL/kg, respiratory rate of 30 breaths/min, and positive end-expiratory pressure of 5 cmH2O. Anesthesia was maintained with inhaled sevoflurane. A flexible bronchoscope (outer diameter: 3.7 mm) was inserted through the trachea by a pulmonologist and advanced beyond the main bronchus to the lateral segment orifice in the right lower lobe (Figure 3). A 1-mm Teflon catheter was introduced through the working channel of the bronchoscope and was positioned within the segmental bronchus under continuous endoscopic visualization. Photograph of cancer cell inoculation procedure. Under anesthesia, a thoracoscope was inserted into the rabbit’s intercostal space, and a bronchoscope was introduced to guide the inoculation of cancer cells. This allowed real-time confirmation of accurate delivery to the target site. For simultaneous thoracoscopic monitoring, a small intercostal incision was made to introduce a thoracoscope, and 10 mL of air was insufflated into the pleural cavity to induce a temporary pneumothorax and secure the visual field. The lateral segment of the right lower lobe was identified on the thoracoscopic monitor. Using a Teflon catheter, gentle pressure was applied to confirm the protrusion of the targeted parenchymal area, and then 0.6 mL of VX2 tumor cell suspension was injected into the distal bronchus of the target segment (Figure 4). Bronchoscopic cancer cell inoculation under thoracoscopic guidance. (A) An endoscope is inserted through the rabbit bronchus, and a Teflon catheter is advanced into the target segmental bronchus. (B) Lung expansion subsequent to cancer cell injection. Five rabbits were administered the VX2 tumor cell suspension alone, whereas the remaining five received a VX2-lipiodol mixture. After injection, thoracoscopic observation confirmed the expansion of the lateral segment. Air from the thoracic cavity was expelled using a 23-G needle to eliminate pneumothorax. Lung re-expansion was verified before the thoracoscope was removed, and the chest wall was closed. Chest tube placement was not required. Residual pleural air and fluid were aspirated as completely as possible via an angiocatheter prior to wound closure, and the approximately 5-mm intercostal incision was managed with povidone-iodine dressing every other day until full recovery.Tumor growth was monitored using chest radiographs obtained 2 and 4 weeks after injection. At 5 weeks, the animals were euthanized, and the trachea with the ipsilateral lung was excised en bloc for pathological evaluation to determine tumor malignancy and histological characteristics. Statistical analysis Given the exploratory, model-development design and the small number of animals, study outcomes were summarized using descriptive statistics. The number and proportion of animals showing tumor formation and peripheral tumor localization were reported for each group. No formal statistical hypothesis testing was performed, and no statistical software was used for inferential analysis. Results Animal characteristics and procedure-related mortality Twenty New Zealand White rabbits were used in the present study. During the initial phase (n1-1 to n1-5 and n2-1 to n2-5), 10 rabbits with an average body weight of 2 kg were used (Table 1). Mortality was high during anesthesia induction, which was attributed to hypoxemia caused by transient airway obstruction from the bronchoscope used for tumor cell delivery. The small tracheal diameter in these animals may have further increased the risk of procedure-related complications, such as parenchymal injury, during bronchoscope advancement. Table 1Results of cancer cell inoculation in experimental rabbitsVariablesSubgroupInjection materialTumor formationPeripheral lung tumor formationResultGroup 1n1-1VX2/lipiodol––Deadn1-2VX2/lipiodol––Deadn1-3VX2/lipiodol––Deadn1-4VX2/lipiodol––Deadn1-5VX2/lipiodol––Deadn1-6VX2/lipiodol++Aliven1-7VX2/lipiodol++Aliven1-8VX2/lipiodol++Aliven1-9VX2/lipiodol+–Alive. Cardiac or pleural invasionn1-10VX2/lipiodol––AliveGroup 2n2-1VX2–N/ADeadn2-2VX2–N/ADeadn2-3VX2––Deadn2-4VX2––Deadn2-5VX2––Aliven2-6VX2––Aliven2-7VX2––Aliven2-8VX2––Aliven2-9VX2+–Alive. Cardiac or pleural invasionn2-10VX2+–Alive. Cardiac or pleural invasion–, tumor formation not observed; +, tumor formation observed. N/A, not available. Results of cancer cell inoculation in experimental rabbits –, tumor formation not observed; +, tumor formation observed. N/A, not available. Larger rabbits with an average body weight of 3 kg were used in the final phase. No further mortality occurred during anesthesia induction or during the procedure. Optimization of tumor cell suspension During the initial VX2 cell injections, the tumor suspension had a low viscosity, leading to diffusion beyond the intended site. To address this, a high-viscosity radiopaque contrast agent (lipiodol ultra fluid, Guerbet) was mixed with the VX2 cell suspension to enhance localization (Figure 5). The lipiodol mixture had higher viscosity and polymerized gradually, thereby preventing leakage from the inoculation site. Cancer cell inoculation mixture. Lipiodol was administered before and after the cancer cell suspension to prevent leakage. Experimental groups Animals were divided into experimental groups 1 (VX2/lipiodol mixture, 10 rabbits) and 2 (VX2 suspension only, 10 rabbits). Within each group, the mean body weights of the n1-1 to n1-5 and n2-1 to n2-5 rabbits were 2.1 and 2.0 kg, whereas those of n1-6 to n1-10 and n2-6 to n2-10 rabbits were 3.0 and 2.9 kg, respectively (Table 1). Outcomes in group 1 (VX2/lipiodol) In group 1, five rabbits (n1-1 to n1-5) died during anesthesia induction, corresponding to 50% mortality in lighter animals. The remaining five rabbits (n1-6 to n1-10) survived, among which four developed visible pulmonary tumors. Of these, the desired peripheral lung tumor model was established in three (Figure 6). However, in one animal, a localized lesion failed to form despite lipiodol use, and the tumor spread to adjacent areas, which was attributed to a technical error during injection. Photographs of resected lungs and tumor xenografts. (A) Lung tumors were formed but spread diffusely without localization. (B,C) Peripheral lung tumors were successfully established. Outcomes in group 2 (VX2-only) In group 2, lung tumors developed in two rabbits; however, neither developed localized lesions. Instead, both exhibited invasive growth involving the pleura and heart (Figure 6). During the injection, the VX2 suspension often leaked outside the target bronchus. Four deaths occurred in this group, all in 2-kg rabbits during anesthesia induction, similar to group 1. Formation of peripheral lung tumors All three peripheral lung tumors were successfully established in rabbits injected with the VX2/lipiodol mixture. In contrast, among the rabbits lacking localized lesions, one was from the VX2/lipiodol group and two were in the VX2-only group. These findings indicate that mixing VX2 cells with lipiodol substantially improved tumor localization and model reproducibility. Postmortem evaluation At 5 weeks post-injection, all surviving rabbits were euthanized using a high concentration of carbon dioxide. The thoracic cavity was inspected to evaluate gross tumor morphology, pleural leakage, and metastatic spread. The trachea and the right lung were resected en bloc for macroscopic examination. Tumor specimens were fixed in 10% neutral-buffered formalin and subjected to histopathological analyses. Microscopic evaluation confirmed the presence of malignant tumor cells in all resected lesions (Figure 7). Postoperative chest radiographs, while inadequate for detailed tumor characterization, were sufficient to assess for pneumothorax and hemothorax; neither complication was observed in any animal. All surgical incisions healed without wound infection. The acute deaths occurring during anesthesia induction were presumed, though not definitively confirmed, to result from hypoxemia secondary to transient bronchoscope-related airway obstruction. Histopathological findings. Cancer cells and alveolar epithelial cells were observed (hematoxylin and eosin staining, ×200). Discussion Lung cancer has a multifactorial etiology involving genetic mutations, tobacco exposure (active and passive smoking), and environmental factors, such as air pollution, infections, and occupational hazards, that contribute to non-small cell lung cancer (NSCLC) development. NSCLC accounts for approximately 85% of all lung cancers and encompasses several histological and molecular subtypes (13,14). According to the World Health Organization, the major subtypes include adenocarcinoma (40–50%), squamous cell carcinoma (20–30%), and large cell carcinoma (5–10%) (15). Current NSCLC management strategies include surgery, radiotherapy, chemotherapy, targeted molecular therapy, and immunotherapy. Treatment outcomes vary depending on the tumor stage, histology, genetic profile, and patient performance status (16). Over the past few decades, researchers have developed preclinical animal models for NSCLC research, including cell line-derived xenografts, genetically engineered mouse models, and patient-derived xenografts. These models have helped elucidate tumor biology and oncogenic mechanisms (17,18). In the early 20th century, researchers primarily relied on spontaneous or chemically induced tumors in animals such as mice and dogs to study tumorigenesis. Although these methods provide valuable baseline observations, the random nature of tumor induction and limited reproducibility restrict our understanding of tumor behavior (19,20). In the 1950s, the VX2 tumor model was introduced in Japan, marking a milestone in experimental oncology research. The VX2 model enabled rapid tumor formation in rabbits and is currently widely used in lung cancer research. However, earlier approaches often resulted in imprecise tumor localization and uncontrolled tumor cell dissemination after injection (21). Advances in high-resolution imaging technologies, including CT and positron emission tomography, have improved real-time monitoring of tumor growth and distribution; however, spatial accuracy remains suboptimal. In the 1990s, genetically engineered mouse models revolutionized cancer research by allowing the controlled manipulation of specific oncogenes (e.g., Kras) or tumor-suppressor genes and provided insights into the molecular mechanisms of tumor initiation and progression. These technological advances have improved our ability to observe subtle tumor evolution and evaluate targeted therapies and interventional procedures (22). Despite these advances, no animal model can fully recapitulate the biology of human cancers. The physiological and pathological differences between animals and humans often limit the translational potential of preclinical findings. Moreover, the development and maintenance of animal models are expensive, time-consuming, and ethically challenging. Nevertheless, animal models are essential to better understand oncogenesis and evaluate the efficacy of novel therapeutic agents. Therefore, efficient and reproducible methods are required. In this study, a precise and efficient orthotopic lung cancer model was developed using white New Zealand White rabbits. Using thoracoscopic and bronchoscopic guidance, tumor cell injection was monitored in real-time, enabling accurate targeting and minimizing leakage compared with traditional injection methods. Furthermore, mixing VX2 cells with high-viscosity lipiodol enhanced tumor localization and containment, resulting in consistent formation of peripheral lung tumors. In contrast, previous studies have frequently resulted in multiple lesions, central tumor growth, or invasion into adjacent structures, such as the pleura and heart. The improved localization strengthens the reliability and translational value of the experimental data. This injection technique may provide a foundation for future research into novel anticancer drugs, SBRT, or combined systemic and local therapies. However, this study has some limitations. First, the VX2 model does not fully replicate the biological characteristics of human lung cancer. Although VX2 tumors are useful under specific experimental conditions, their similarity to human histological and molecular subtypes is limited. Therefore, caution should be exercised when extrapolating these findings to other human diseases. Comparative studies using multiple models are required to improve translational relevance. Second, the sample size of the study was limited to 20 rabbits. Although suitable for a preliminary assessment, this number may be insufficient to achieve statistical robustness. Therefore, future studies should include larger cohorts and additional variables. Third, simultaneous thoracoscopic and bronchoscopic techniques are associated with technical and financial barriers. Importantly, these methods require specialized equipment and procedural expertise, which may limit their widespread adoption. More accessible and cost-efficient alternatives, such as simplified devices or different animal species, may broaden their applicability. Furthermore, cross-model validation using human-like tumor systems is required to confirm the generalizability of this model. Fourth, the rabbit trachea and segmental bronchi are anatomically narrow and short, leaving minimal tolerance for catheter positioning; even slight variation in catheter insertion depth could cause airway obstruction or tumor cell leakage beyond the target segment, as observed in rabbit n1-9, contributing to the modest success rate observed in this pilot study. Future studies using larger rabbits, larger-airway species such as dogs, a smaller-diameter bronchoscope, and closer collaboration with experienced interventional pulmonologists may further improve procedural consistency and success rate. Fifth, tumor monitoring in this study relied on plain chest radiography rather than thin-section CT, as dedicated small-animal CT imaging was not available at our institution; radiography has limited sensitivity for detecting subtle pleural micrometastasis or mediastinal lymph node involvement. Future studies are planned to utilize CT imaging available at a collaborating institution to allow more precise quantification of tumor growth and detection of occult metastatic spread. In future studies, we plan to systematically evaluate procedure-related complications—including pneumothorax, hemothorax, and surgical trauma—in addition to mortality, and to analyze their relationship with procedural outcomes to further refine this model. Conclusions This study presents a novel high-precision approach for developing an orthotopic rabbit lung cancer model to be used as an experimental platform for translational research. By achieving localized and reproducible tumor formation through the image-guided bronchoscopic inoculation of tumor cells with lipiodol, this model provides a tool for investigating SBRT optimization, combined systemic therapy, and emerging local treatment modalities. This model may contribute to the advancement of preclinical lung cancer research and may facilitate the development of more effective therapeutic strategies for patients with lung cancer. Supplementary The article’s supplementary files as Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1080/prf